Nitazoxanide Exerts Immunomodulatory Effects on Peripheral Blood Mononuclear Cells from Type 2 Diabetes Patients

Background: Type 2 diabetes (T2D) is a low-grade inflammatory condition with abnormalities in the immune response mediated by T lymphocytes and macrophages. Drug repositioning for immunomodulatory molecules is an attractive proposal for treating T2D. Nitazoxanide (NTZ) is a broad-spectrum drug with...

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo-Salazar, Mauricio, Sánchez-Muñoz, Fausto, Springall del Villar, Rashidi, Navarrete-Vázquez, Gabriel, Hernández-DiazCouder, Adrián, Mojica-Cardoso, Carlos, García-Jiménez, Sara, Toledano-Jaimes, Cairo, Bernal-Fernández, Germán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699442/
https://www.ncbi.nlm.nih.gov/pubmed/34944461
http://dx.doi.org/10.3390/biom11121817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699442/
https://www.ncbi.nlm.nih.gov/pubmed/34944461
http://dx.doi.org/10.3390/biom11121817

Ejemplares similares